1st
| 논문
|
2021년 9월 26일 김규원 김예일 김현수 안태영
| - Anti-senescent drug screening by deep learning-based morphology senescence scoring - Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages - Cancer selective target degradation by folate-caged PROTACs - mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach
|
2nd
| 논문
|
2021년 11월 14일 김예일 김현수
| - Identification and treatment of T2-low asthma in the era of biologics - Cargo recognition and degradation by selective autophagy
|
3rd
| 논문
|
2021년 11월 21일 김규원 안태영
| - Mitochondria as a therapeutic target for common pathologies - Engineering precision nanoparticles for drug delivery
|
4th
| 논문
|
2021년 12월 26일 김예일 김현수 한병우 교수
| - Sweet death: fructose as a metabolic toxin that targets the gut-liver axis - Targeted degradation of oncogenic KRAS-G12C by VHL-recruiting PROTACs
|
5th
| 논문
|
2022년 1월 9일 안시현 안이진
| - mRNA vaccines for infectious diseases: principles, delivery and clinical translation - Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
|
6th
| 논문
|
2022년 1월 23일 성지윤 안태영 임태환 차혁진 교수
| - Genome-editing-mediated restructuring of tumor immune microenvironment for prevention of metastasis - Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR-T cell engineering - Synaptic adhesion molecule IgSF11 regulates synaptic transmission and plasticity
|
7th
| 논문
|
2022년 2월 19일 김예일 안이진 이나영 박사
| - Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome - COVID-19 and liver disease: mechanistic and clinical perspectives
|
8th
| 논문
|
2022년 3월 6일 김규원 임태환
| - The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation - Bispecific antibodies: a mechanistic review of the pipeline
|
9th
| 논문
|
2022년 3월 20일 안시현 안태영
| - Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis - Hyaluronic acid-bilirubiin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
|
10th
| 논문
|
2022년 4월 3일 김현수 성지윤
| - Advances in protein structure prediction and design - A novel nanoprobe for targeted imaging and photothermal/photodynamic therapy of lung cancer
|
11th
| 논문
|
2022년 5월 1일 박희준 이승준
| - Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing - A decade of iontronic delivery devices
|
12th
| 논문
|
2022년 5월 15일 임호균 홍채영
| - A basic insight into aptamer-drug conjugates (ApDCs) - Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease
|
13th
| 논문
|
2022년 6월 26일 변재인 임태환
| - Cell-type specific Shank2 deletion in mice leads to differential synaptic and behavioral phenotypes - The renaissance of chemically generated bispecific antibodies
|
14th
| 논문
|
2022년 7월 3일 안이진 백진식
| - Third generation EGFR TKIs: current data and future directions - Endolysin, a Promising Solution against Antimicrobial Resistance
|
15th
| 논문
|
2022년 7월 17일 김예일 안시현
| - Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output - The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
|
16th
| 논문
|
2022년 7월 24일 안태영
| - Inducing immune tolerance with dendritic cell-targeting nanomedicines
|
17th
| 논문
|
2022년 7월 31일 김현수 박희준
| - Predicting substrates of the human breast cancer resistance protein using a support vector machine method - Biased allosteric modulators: new frontiers in GPCR drug discovery
|
18th
| 논문
|
2022년 8월 7일 성지윤 이승준
| - Near-infrared light triggered nanobomb for in situ on-demand maximization of photothermal/photodynamic efficacy for cancer therapy - Metabolic mechanisms of a drug revealed by distortion-free 13C tracer analysis
|
19th
| 논문
|
2022년 8월 14일 임호균 홍채영
| - Discovery of selective RNA-binding small molecules by affinity-selection mass spectrometry - Discovery and synthesis of a pyrimidine-based Aurora Kinase inhibitor to reduce levels of MYC oncoproteins
|
20th
| 논문
|
2022년 8월 21일 변재인 임태환 배낙현 박사
| - A specific amyloid-beta assembly in the brain impairs memory - The renaissance of chemically generated bispecific antibodies
|
21st
| 논문
|
2022년 8월 28일 안이진 백진식 신상 박사
| - Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling - Molecular therapies and precision medicine for hepatocellular carcinoma
|
22nd
| 논문
|
2022년 9월 15일 김예일 김현수
| - Fragment-based covalent ligand discovery - FGF21: An emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases
|
23rd
| 논문
|
2022년 9월 19일 김규원 임태환
| - NAD+ metabolism and its roles in cellular processes during ageing - A cytokine receptor masked IL2 prodrug selectively activates tumor infiltrating lymphocytes or potent antitumor therapy
|
24th
| 논문
|
2022년 10월 3일 임호균 홍채영
| - The tumor microenvironment in pancreatic cancer – clinical challenges and opportunities - Non-coding RNA networks in cancer
|
25th
| 논문
|
2022년 10월 31일 변재인 안선우
| - Noninvasive optical activation of Flp recombinase for genetic manipulation in deep mouse brain regions - Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway
|